Company intelligence / Profile preview

Flaredown

Ownership: Private
Development stage: Commercial

Overview

Flaredown provides a comprehensive digital tool for patients to track symptoms, medications, food intake, mental health factors, weather/environmental triggers, and activities. The goal is to help individuals identify personal triggers and effective treatments for chronic illnesses. Data are anonymized and shared with researchers to advance understanding of chronic disease management. There are no clinical trial results as it is not developing therapeutics.

Therapeutic areas: Other
Modalities: Non-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships reported. Data may be shared with academic researchers/data scientists in anonymized form

Beyond the preview

Go deeper on Flaredown.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flaredown.

Explore the full profile